Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 492

1.

MRI with diffusion-weighted imaging to predict feasibility of complete cytoreduction with the peritoneal cancer index (PCI) in advanced stage ovarian cancer patients.

Engbersen MP, Van' T Sant I, Lok C, Lambregts DMJ, Sonke GS, Beets-Tan RGH, van Driel WJ, Lahaye MJ.

Eur J Radiol. 2019 May;114:146-151. doi: 10.1016/j.ejrad.2019.03.007. Epub 2019 Mar 15.

PMID:
31005166
2.

Reporting quality of pilot clinical trials in chronic kidney disease patients on hemodialysis: a methodological survey.

Kosa SD, Monize J, Leenus A, Leenus S, Samra S, Szwiega S, Shi D, Valvasori S, Gafni A, Lok CE, Thabane L.

Pilot Feasibility Stud. 2019 Apr 6;5:53. doi: 10.1186/s40814-019-0436-3. eCollection 2019.

3.

Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Chan CT, Blankestijn PJ, Dember LM, Gallieni M, Harris DCH, Lok CE, Mehrotra R, Stevens PE, Wang AY, Cheung M, Wheeler DC, Winkelmayer WC, Pollock CA; Conference Participants.

Kidney Int. 2019 Apr 12. pii: S0085-2538(19)30138-3. doi: 10.1016/j.kint.2019.01.017. [Epub ahead of print]

PMID:
30987837
4.

Shortcomings in the evaluation of biomarkers in ovarian cancer: a systematic review.

Olsen M, Ghannad M, Lok C, Bossuyt PM.

Clin Chem Lab Med. 2019 Apr 8. pii: /j/cclm.ahead-of-print/cclm-2019-0038/cclm-2019-0038.xml. doi: 10.1515/cclm-2019-0038. [Epub ahead of print] Review.

PMID:
30956227
5.

The effect of adjuvant chemotherapy on survival in patients with FIGO stage I high-grade serous ovarian cancer.

van Baal JOAM, Van de Vijver KK, Algera MD, van der A MA, Sonke GS, van Driel WJ, Kenter GG, Amant FC, Lok CAR.

Gynecol Oncol. 2019 Apr 1. pii: S0090-8258(19)30492-5. doi: 10.1016/j.ygyno.2019.03.257. [Epub ahead of print]

PMID:
30948193
6.

Nutritional Mobile Applications for CKD Patients: Systematic Review.

Kosa SD, Monize J, D'Souza M, Joshi A, Philip K, Reza S, Samra S, Serrago B, Thabane L, Gafni A, Lok CE.

Kidney Int Rep. 2018 Nov 29;4(3):399-407. doi: 10.1016/j.ekir.2018.11.016. eCollection 2019 Mar.

7.

Acrodermatitis continua of Hallopeau response to optimized biological therapy.

Adas A, Dadban A, Arnault JP, Chaby G, Lok C.

Dermatol Online J. 2019 Feb 15;25(2). pii: 13030/qt93s9w1p3.

8.

A Multifunctional Hydrogel Delivers Gold Compound and Inhibits Human Lung Cancer Xenograft.

Lee P, Lok CN, Che CM, Kao WJ.

Pharm Res. 2019 Mar 8;36(4):61. doi: 10.1007/s11095-019-2581-z.

PMID:
30850894
9.

A single typical trichoscopic feature is predictive of tinea capitis - a prospective multicenter study.

Dhaille F, Dillies AS, Dessirier F, Reygagne P, Diouf M, Balthazard T, Lombart F, Hébert V, Chopinnaud M, Verneuil L, Becquart C, Delaporte E, Lok C, Chaby G.

Br J Dermatol. 2019 Mar 7. doi: 10.1111/bjd.17866. [Epub ahead of print]

PMID:
30844082
10.

Non-reimbursed costs incurred by living kidney donors: A case study from Ontario, Canada.

Barnieh L, Klarenbach S, Arnold J, Cuerden M, Knoll G, Lok C, Sontrop JM, Miller M, Prasad GVR, Przech S, Garg AX; Donor Nephrectomy Outcomes Research (DONOR) Network.

Transplantation. 2019 Mar 1. doi: 10.1097/TP.0000000000002685. [Epub ahead of print]

PMID:
30830039
11.

Localized mycosis fungoides treated with laser-assisted photodynamic therapy: a case series.

Dairi M, Dadban A, Arnault JP, Lok C, Chaby G.

Clin Exp Dermatol. 2019 Mar 1. doi: 10.1111/ced.13936. [Epub ahead of print] No abstract available.

PMID:
30825216
12.

Plasmonic metal nanoparticles as efficient mass tags for ion signal amplification and ultrasensitive detection of protein markers.

Cheng YH, Cheung YF, Siu-Chung Tam T, Lok CN, Sun H, Ng KM.

Anal Chim Acta. 2019 May 9;1055:1-6. doi: 10.1016/j.aca.2018.12.057. Epub 2019 Jan 9.

PMID:
30782360
13.

Con: vascular access surveillance in mature fistulas: is it worthwhile?

Moist L, Lok CE.

Nephrol Dial Transplant. 2019 Feb 14. pii: gfz004. doi: 10.1093/ndt/gfz004. [Epub ahead of print]

PMID:
30768169
14.

Plasmonic gold nanoparticles as multifaceted probe for tissue imaging.

Cheng YH, Tam TS, Chau SL, Lai SK, Tang HW, Lok CN, Lam CW, Ng KM.

Chem Commun (Camb). 2019 Feb 28;55(19):2761-2764. doi: 10.1039/c9cc00356h.

PMID:
30766990
15.

Luminescent ruffled iridium(iii) porphyrin complexes containing N-heterocyclic carbene ligands: structures, spectroscopies and potent antitumor activities under dark and light irradiation conditions.

Lam TL, Tong KC, Yang C, Kwong WL, Guan X, Li MD, Kar-Yan Lo V, Lai-Fung Chan S, Lee Phillips D, Lok CN, Che CM.

Chem Sci. 2018 Oct 10;10(1):293-309. doi: 10.1039/c8sc02920b. eCollection 2019 Jan 7.

16.

The results of treatment with high-dose chemotherapy and peripheral blood stem cell support for gestational trophoblastic neoplasia.

Frijstein MM, Lok CAR, Short D, Singh K, Fisher RA, Hancock BW, Tidy JA, Sarwar N, Kanfer E, Winter MC, Savage PM, Seckl MJ.

Eur J Cancer. 2019 Mar;109:162-171. doi: 10.1016/j.ejca.2018.12.033. Epub 2019 Feb 4.

PMID:
30731277
17.

Detection and characterization of type B influenza virus from influenza-like illness cases during the 2017-2018 winter influenza season in Beijing, China.

Zhu D, Lok C, Chao S, Chen L, Li R, Zhao Z, Dong J, Qin K, Zhao X.

Arch Virol. 2019 Apr;164(4):995-1003. doi: 10.1007/s00705-019-04160-w. Epub 2019 Feb 7.

PMID:
30729995
18.

Tamoxifen and pregnancy: an absolute contraindication?

Schuurman TN, Witteveen PO, van der Wall E, Passier JLM, Huitema ADR, Amant F, Lok CAR.

Breast Cancer Res Treat. 2019 Feb 1. doi: 10.1007/s10549-019-05154-7. [Epub ahead of print] Review.

PMID:
30707336
19.

Cutaneous lymphoid hyperplasia arising in pre-existing morphea plaques treated with methotrexate.

Dairi M, Arnault JP, Dadban A, Lombart F, Attencourt C, Ortonne N, Lok C, Chaby G.

JAAD Case Rep. 2019 Jan 16;5(2):127-130. doi: 10.1016/j.jdcr.2018.11.005. eCollection 2019 Feb. No abstract available.

20.

Is there uniformity in definitions and treatment of gestational trophoblastic disease in Europe?

Frijstein MM, Lok CAR, Coulter J, van Trommel NE, Ten Kate-Booij MJ, Golfier F, Seckl MJ, Massuger LFAG.

Int J Gynecol Cancer. 2019 Jan;29(1):108-112. doi: 10.1136/ijgc-2018-000028.

PMID:
30640691
21.

Hemodialysis vascular access in the elderly-getting it right.

Viecelli AK, Lok CE.

Kidney Int. 2019 Jan;95(1):38-49. doi: 10.1016/j.kint.2018.09.016. Review.

PMID:
30606427
22.

Cardiovascular magnetic resonance left ventricular strain in end-stage renal disease patients after kidney transplantation.

Gong IY, Al-Amro B, Prasad GVR, Connelly PW, Wald RM, Wald R, Deva DP, Leong-Poi H, Nash MM, Yuan W, Gunaratnam L, Kim SJ, Lok CE, Connelly KA, Yan AT.

J Cardiovasc Magn Reson. 2018 Dec 17;20(1):83. doi: 10.1186/s12968-018-0504-5.

23.

Determinants of Left Ventricular Characteristics Assessed by Cardiac Magnetic Resonance Imaging and Cardiovascular Biomarkers Related to Kidney Transplantation.

Prasad GVR, Yan AT, Nash MM, Kim SJ, Wald R, Wald R, Lok C, Gunaratnam L, Karur GR, Kirpalani A, Connelly PW.

Can J Kidney Health Dis. 2018 Nov 9;5:2054358118809974. doi: 10.1177/2054358118809974. eCollection 2018.

24.

3D Coculture Models Underline Metastatic Melanoma Cell Sensitivity to Vemurafenib.

Morales D, Lombart F, Truchot A, Maire P, Hussein M, Hamitou W, Vigneron P, Galmiche A, Lok C, Vayssade M.

Tissue Eng Part A. 2019 Jan 18. doi: 10.1089/ten.TEA.2018.0210. [Epub ahead of print]

PMID:
30501565
25.

Subacute cutaneous lupus erythematosus induced by nivolumab: two case reports and a literature review.

Zitouni NB, Arnault JP, Dadban A, Attencourt C, Lok CC, Chaby G.

Melanoma Res. 2019 Apr;29(2):212-215. doi: 10.1097/CMR.0000000000000536.

PMID:
30489484
26.

Management and prognostic factors of epithelioid trophoblastic tumors: Results from the International Society for the Study of Trophoblastic Diseases database.

Frijstein MM, Lok CAR, van Trommel NE, Ten Kate-Booij MJ, Massuger LFAG, van Werkhoven E, Kaur B, Tidy JA, Sarwar N, Golfier F, Winter MC, Hancock BW, Seckl MJ; all the contributors to the ISSTD PSTT/ETT database.

Gynecol Oncol. 2019 Feb;152(2):361-367. doi: 10.1016/j.ygyno.2018.11.015. Epub 2018 Nov 22.

PMID:
30473257
27.

Vulvar Paget disease: a national retrospective cohort study.

van der Linden M, Oonk MHM, van Doorn HC, Bulten J, van Dorst EBL, Fons G, Lok CAR, van Poelgeest MIE, Slangen BMF, Massuger LFAG, de Hullu JA.

J Am Acad Dermatol. 2018 Nov 17. pii: S0190-9622(18)32906-2. doi: 10.1016/j.jaad.2018.11.016. [Epub ahead of print]

PMID:
30458205
28.

Eruptive melanocytic nevi associated with ponatinib.

Devred I, Arnault JP, Adas A, Rea D, Lombart F, Sevestre H, Trudel S, Lok C, Chaby G.

JAAD Case Rep. 2018 Nov 12;4(10):1052-1054. doi: 10.1016/j.jdcr.2018.07.010. eCollection 2018 Nov. No abstract available.

29.

Financial Costs Incurred by Living Kidney Donors: A Prospective Cohort Study.

Przech S, Garg AX, Arnold JB, Barnieh L, Cuerden MS, Dipchand C, Feldman L, Gill JS, Karpinski M, Knoll G, Lok C, Miller M, Monroy M, Nguan C, Prasad GVR, Sarma S, Sontrop JM, Storsley L, Klarenbach S; Donor Nephrectomy Outcomes Research (DONOR) Network.

J Am Soc Nephrol. 2018 Dec;29(12):2847-2857. doi: 10.1681/ASN.2018040398. Epub 2018 Nov 7.

PMID:
30404908
30.

Type 2 diabetes in patients with end-stage kidney disease: influence on cardiovascular disease-related mortality risk.

Lim WH, Johnson DW, Hawley C, Lok C, Polkinghorne KR, Roberts MA, Boudville N, Wong G.

Med J Aust. 2018 Nov 19;209(10):440-446. Epub 2018 Oct 22.

PMID:
30332936
31.

Comparison between Surgical and Endovascular Hemodialysis Arteriovenous Fistula Interventions and Associated Costs.

Arnold RJG, Han Y, Balakrishnan R, Layton A, Lok CE, Glickman M, Rajan DK.

J Vasc Interv Radiol. 2018 Nov;29(11):1558-1566.e2. doi: 10.1016/j.jvir.2018.05.014. Epub 2018 Oct 5.

32.

Embryology, anatomy, physiology and pathophysiology of the peritoneum and the peritoneal vasculature.

Kastelein AW, Vos LMC, de Jong KH, van Baal JOAM, Nieuwland R, van Noorden CJF, Roovers JWR, Lok CAR.

Semin Cell Dev Biol. 2018 Oct 8. pii: S1084-9521(18)30019-3. doi: 10.1016/j.semcdb.2018.09.007. [Epub ahead of print] Review.

PMID:
30253239
33.

Effects of cancer treatment during pregnancy on fetal and child development.

Vandenbroucke T, Verheecke M, Fumagalli M, Lok C, Amant F.

Lancet Child Adolesc Health. 2017 Dec;1(4):302-310. doi: 10.1016/S2352-4642(17)30091-3. Epub 2017 Sep 29. Review.

PMID:
30169185
34.

Is the Kidney Donor Risk Index a Useful Tool in Non-US Patients?

Young A, Knoll GA, McArthur E, Dixon SN, Garg AX, Lok CE, Lam NN, Kim SJ.

Can J Kidney Health Dis. 2018 Jul 27;5:2054358118791148. doi: 10.1177/2054358118791148. eCollection 2018.

35.

Long-term results of thigh arteriovenous dialysis grafts.

Kim D, Bhola C, Eisenberg N, Montbriand J, Oreopoulos G, Lok CE, Roche-Nagle G.

J Vasc Access. 2019 Mar;20(2):153-160. doi: 10.1177/1129729818787994. Epub 2018 Jul 25.

PMID:
30045660
36.

Chemical Printing of Biological Tissue by Gold Nanoparticle-Assisted Laser Ablation.

Chau SL, Tang HW, Cheng YH, Lok CN, Ng KM.

ACS Omega. 2017 Sep 30;2(9):6031-6038. doi: 10.1021/acsomega.7b00385. Epub 2017 Sep 21.

37.

Management and outcome of colorectal cancer during pregnancy: report of 41 cases.

Kocián P, de Haan J, Cardonick EH, Uzan C, Lok CAR, Fruscio R, Halaska MJ, Amant F; Writing Committee of the International Network on Cancer, Infertility and Pregnancy (INCIP) on this particular manuscript.

Acta Chir Belg. 2018 Jul 16:1-10. doi: 10.1080/00015458.2018.1493821. [Epub ahead of print]

PMID:
30010511
38.

A Prospective Clinical Study of a Percutaneous Vascular Access System for Hemodialysis Catheters.

Rajan DK, Moran B, Lobl TJ, Asch MR, Steele AW, Lok CE.

Cardiovasc Intervent Radiol. 2018 Oct;41(10):1513-1519. doi: 10.1007/s00270-018-2031-z. Epub 2018 Jul 13.

PMID:
30006890
39.

Improving precision in prediction: Using kidney failure risk equations as a potential adjunct to vascular access planning.

Inston N, Lok CE.

J Vasc Access. 2019 Jan;20(1):95-97. doi: 10.1177/1129729818786630. Epub 2018 Jul 12.

PMID:
30001661
40.

Antibody-modified conduits for highly selective cytokine elimination from blood.

McAlvin JB, Wylie RG, Ramchander K, Nguyen MT, Lok CK, Moroi M, Shomorony A, Vasilyev NV, Armstrong P, Yang J, Lieber AM, Okonkwo OS, Karnik R, Kohane DS.

JCI Insight. 2018 Jul 12;3(13). pii: 121133. doi: 10.1172/jci.insight.121133.

41.

Shotgun Proteomics and Quantitative Pathway Analysis of the Mechanisms of Action of Dehydroeffusol, a Bioactive Phytochemical with Anticancer Activity from Juncus effusus.

Chang IS, Sy LK, Cao B, Lum CT, Kwong WL, Fung YE, Lok CN, Che CM.

J Proteome Res. 2018 Jul 6;17(7):2470-2479. doi: 10.1021/acs.jproteome.8b00227. Epub 2018 Jun 21.

PMID:
29812950
42.

Congenital melanocytic naevus and congenital strabismus.

Dubois C, Dadban A, Denamps J, Arnault JP, Lok C, Chaby G.

Clin Exp Dermatol. 2019 Mar;44(2):213-214. doi: 10.1111/ced.13622. Epub 2018 May 28. No abstract available.

PMID:
29808480
43.

A Patient with Hemodialysis Access Problems.

Niyyar VD, Lok CE.

Clin J Am Soc Nephrol. 2018 Sep 7;13(9):1410-1412. doi: 10.2215/CJN.02610218. Epub 2018 May 18. No abstract available.

PMID:
29777015
44.

Livedoid Vasculopathy: A French Observational Study Including Therapeutic Options.

Gardette E, Moguelet P, Bouaziz JD, Lipsker D, Dereure O, Le Pelletier F, Lok C, Maisonobe T, Bessis D, Conard J, Francès C, Barete S.

Acta Derm Venereol. 2018 Oct 10;98(9):842-847. doi: 10.2340/00015555-2965.

45.

Does peritoneal dialysis have a role in urgent-start end-stage kidney disease?

McQuillan RF, Lok CE.

Semin Dial. 2018 Jul;31(4):325-331. doi: 10.1111/sdi.12700. Epub 2018 Apr 19. Review.

PMID:
29676003
46.

Lower-limb Ulcers in Systemic Sclerosis: A Multicentre Retrospective Case-control Study.

Bohelay G, Blaise S, Levy P, Claeys A, Baudot N, Cuny JF, Maillard H, Granel-Brocard F, Boyé T, Lok C, Bénéton N, Francès C, Senet P.

Acta Derm Venereol. 2018 Jul 11;98(7):677-682. doi: 10.2340/00015555-2939.

47.

Duration of Living Kidney Transplant Donor Evaluations: Findings From 2 Multicenter Cohort Studies.

Habbous S, Arnold J, Begen MA, Boudville N, Cooper M, Dipchand C, Dixon SN, Feldman LS, Goździk D, Karpinski M, Klarenbach S, Knoll GA, Lam NN, Lentine KL, Lok C, McArthur E, McKenzie S, Miller M, Monroy-Cuadros M, Nguan C, Prasad GVR, Przech S, Sarma S, Segev DL, Storsley L, Garg AX; Donor Nephrectomy Outcomes Research (DONOR) Network.

Am J Kidney Dis. 2018 Oct;72(4):483-498. doi: 10.1053/j.ajkd.2018.01.036. Epub 2018 Mar 24.

48.

Validity of administrative database code algorithms to identify vascular access placement, surgical revisions, and secondary patency.

Al-Jaishi AA, Moist LM, Oliver MJ, Nash DM, Fleet JL, Garg AX, Lok CE.

J Vasc Access. 2018 Nov;19(6):561-568. doi: 10.1177/1129729818762008. Epub 2018 Mar 12.

PMID:
29529926
49.

Vascular Access Practice Patterns in Canada: A National Survey.

Dumaine C, Kiaii M, Miller L, Moist L, Oliver MJ, Lok CE, Hiremath S, MacRae JM.

Can J Kidney Health Dis. 2018 Feb 28;5:2054358118759675. doi: 10.1177/2054358118759675. eCollection 2018.

50.

Clinical Trial End Points for Hemodialysis Vascular Access: Background, Rationale, and Definitions.

Shenoy S, Allon M, Beathard G, Brouwer-Maier D, Dember LM, Glickman M, Lee C, Litchfield T, Lok C, Huber T, Roy-Chaudhury P, Work J, West M, Wasse H.

Clin J Am Soc Nephrol. 2018 Mar 7;13(3):490-494. doi: 10.2215/CJN.13321216. Epub 2018 Feb 27. No abstract available.

Supplemental Content

Support Center